Navigation Links
InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting

BURLINGTON, Mass., Sept. 11 /PRNewswire/ -- InfraReDx today announced its preliminary schedule of events at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, scheduled from Monday, September 21st to Friday, September 25th, in San Francisco, CA. at the Moscone Center. This scientific meeting is one of the world's largest events for those performing cardiac diagnostics and interventions.

The LipiScan(TM) Coronary Imaging System will be displayed in the "Emerging Technologies" section at booth # 2410. Schedule of InfraReDx Events at TCT 2009 are as follows:

Monday, September 21st

On behalf of Cardiovascular Research Foundation, Dr. James Muller, founder and CEO of InfraReDx, has been invited to participate as a guest speaker titled:

"Vulnerable Plaque: Emerging Directions for Diagnosis and Treatment: Near Infrared Spectroscopy I: Technology and validation."

  • 2:40 pm in room # 130 at the Moscone Center.

Friday, September 25th

InfraReDx sponsored Breakfast Symposium:

"Beyond Angiography: NIR Spectroscopy and Other Methods for Plaque Characterization."

  • 6:30 am Breakfast, 7:00 am Symposium in room #120 at the Moscone Center. Presenters include: Dr. Cindy Grines (Beaumont Hospital), Dr. Gregg W. Stone (Presbyterian/Columbia), Dr. Emmanouil Brilakis (Dallas VA), Dr. Brijeshwar Maini (Moffitt Heart and Vascular), Dr. Patrick Serruys (Erasmus Medical Center), and Dr. James E. Muller (InfraReDx).

About InfraReDx, Inc.

InfraReDx, Inc., headquartered in Burlington, Massachusetts, was founded in 1998 and is a privately-funded medical device company developing a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify and characterize vulnerable plaque in the coronary arteries. For more information, visit

About TCT 2009

TCT is organized by the Cardiovascular Research Foundation, which is dedicated to research and education in the broad subspecialty of interventional cardiology and endovascular medicine. The TCT meeting is the primary annual meeting for the world-wide interventional cardiology community. For more information, visit

Company Contacts:

    Dr. Muller Contact:        Investor Contact:        Media Contact:
    Carolyn Rogers             Jeff Mazur               Jim Dillon
    InfraReDx, Inc.            InfraReDx, Inc.          InfraReDx, Inc.
    (781) 345-9644             (781) 345-9626           (781) 345-9679

SOURCE InfraReDx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
2. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
3. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
4. Scottsdale Facility to Be First in U.S. to Showcase True REST Technology
5. Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase
6. B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase
7. Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th
8. InVitrias Cellastim Showcased in Nature Article
9. Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting
10. InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
11. ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
Post Your Comments:
(Date:11/26/2015)... UTRECHT, the Netherlands , November 26, 2015 /PRNewswire/ ...   A new combination approach blends immunotherapy ... --> A new combination approach blends immunotherapy with ... A new combination approach blends immunotherapy with ... the Netherlands has found that immunotherapy ...
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
(Date:11/26/2015)... 26, 2015 ... "2016 Future Horizons and Growth Strategies ... Market: Supplier Shares, Country Segment Forecasts, Competitive ... offering. --> ) has ... Future Horizons and Growth Strategies in the ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... Dr. Thomas ... Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph ... that both STEMI and Sepsis conditions present in similar ways and require time-critical intervention ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the first ... annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the International ... November 11th, 2015. The conference was held at the Hawaii Convention Center in ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of a ... ™ attracts volunteers together who want to combine talents and resources to help ... in the process. The non-profit launched its first major fundraiser on November 6, ...
(Date:11/25/2015)... ... ... Dr. John Pierce, Medical Director at the Ageless Forever clinic in Las ... Pro laser therapy cap. FDA cleared for safety and efficacy, the Capillus272 offers men ... surgery, prescription pills, or topical foams. , “Capillus272™ Pro is a home-use device ...
Breaking Medicine News(10 mins):